骨密度T值与老年冠心病的相关性

doi:10.19739/j.cnki.issn1001-9510.2020.03.008

Abstract
Figure/Table
References
Related Citation (5)

Download: PDF (708 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the correlation between bone mineral density T value and coronary heart disease in the elderly.Methods Retrospective analysis was performed on 512 elderly patients who underwent coronary angiography and bone mineral density examination.According to the results of coronary angiography, 273 patients in the coronary heart disease group and 239 patients in the non-coronary heart disease group. According to the results of DXA bone mineral density examination, there were 302 cases of low bone density group and 210 cases of normal bone density group. The general conditions of each group of patients, the difference of laboratory test indicators, and bone density T value were compared. Logistic regression analysis was used to analyze the risk factors of coronary heart disease in the elderly.Results In 512 elderly patients, the T-value of bone density was lower in the coronary heart disease group and the risk of low bone mineral density was higher in the non-coronary heart disease group (P＜0.05 or＜0.01). Compared with the normal bone density group, the group with low bone mineral density had the high proportion of older, female and diabetic patients, the T-value of bone mineral density was lower, and uric acid was higher (P＜0.05 or＜0.01). Correlation analysis showed that the bone density T value was negatively correlated with age, ALP, FBG (P<0.01), the bone density T value was positively correlated with uric acid (P<0.001). Regression analysis showed that aging, diabetes, were risk factors for low bone density. The results of single factor and multivariate logistic regression analysis showed that high bone density T value was an independent risk factor for coronary heart disease (P<0.05). Conclusion Low bone density T value is an independent risk factor for the onset of coronary heart disease in the elderly.

Key words： coronary heart disease coronary artery calcification risk factor bone mineral density

Received: 18 December 2019

PACS:

R541.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Yuanyuan
	CUI Jianguo
	QI Jie
	CHANG Jiyang
	ZHANG Qingtan

Cite this article:

WANG Yuanyuan,CUI Jianguo,QI Jie, et al. Correlation between bone density T value and coronary heart disease in the elderly[J]. 滨州医学院学报, 2020, 43(3): 190-193.

URL:

http://manu58.magtech.com.cn/Jwk_bzyxy/EN/10.19739/j.cnki.issn1001-9510.2020.03.008 OR http://manu58.magtech.com.cn/Jwk_bzyxy/EN/Y2020/V43/I3/190

[1] 胡盛寿,高润霖,刘力生, 等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] 雍婧雯,王志坚,林徐泽, 等.急性心肌梗死患者患病构成比及住院死亡率变化趋势 [J].中华心血管病杂志,2019,47(3):209-214.
[3] LACEY B, HERRINGTON W G, PREISS D, et al. The Role of Emerging Risk Factors in Cardiovascular Outcomes [J]. Curr Atheroscler Rep, 2017,19(6):28.
[4] 任晓妹,魏芹,邹继红, 等.低骨密度与非糖尿病性冠心病患者冠状动脉病变的相关性[J].中国动脉硬化杂志,2017,25(4):369-372.
[5] 葛保民,高英,赵云兰, 等.老年女性患者骨质疏松与冠心病的相关性研究[J].中国骨质疏松杂志,2015, 27(9):1035-1037.
[6] STARY H C, CHANDLER A B, DINSMORE R E, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association[J].Arteriosclerosis, thrombosis, and vascular biology,1995,15(9):1512-1531
[7] AHMADI N, MAO S S, HAJSADEGHI F, et al.The relation of low levels of bone mineral density with coronary artery calcium and mortality[J]. Osteoporos Int, 2018, 29(7):1609-1616.
[8] GUAN X Q, XUE Y J, WANG J, et al. Low bone mineral density is associated with global coronary atherosclerotic plaque burden in stable angina patients [J]. Clin Interv Aging, 2018,13(9):1475-1483.
[9] XUAN Y, WANG W, ZHANG H ,et al. Osteoporosis is inversely associated with arterial stiffness in the elderly: An investigation using the Osteoporosis Self-assessment Tool for Asians index in an elderly Chinese cohort[J]. J Clin Hypertens (Greenwich),2019,21(3):405-411.
[10] OTSUKA F, SAKAKURA K,YAHAGI K,et al. Has our understanding of calcification in human coronary atherosclerosis progressed?[J].Arteriosclerosis, thrombosis, and vascular biology,2014,34(4):724-736.
[11] GREENLAND P, BONOW R O, BRUNDAGE B H, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) [J]. Circulation, 2007, 49:378-402.
[12] DEMER L L. Vascular calcification: pathobiology of a multifaceted disease [J].Circulation,2008,117(22):2938-2948.
[13] GONNELLI S, CAFFARELLI C, TANZILLI L, et al. Effects of intravenous zoledronate and ibandronate on carotid intima-media thickness, lipids and FGF-23 in postmenopausal osteoporotic women [J]. Bone, 2014, 61:27-32.
[14] MCCARTY M F, DI NICOLANTONIO J J. The molecular biology and pathophysiology of vascular calcification [J]. Postgrad Med, 2014,126: 54-64.
[15] MEMBERS W G, MOZAFFARIAN D, BENJAMIN E J, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association[J]. Circulation, 2016, 133(4): 338-360.
[16] SCHETT G. Effects of inflammatory and anti-inflammatory cytokines on the bone [J]. European journal of clinical investigation, 2011, 41(12):1361-1366.
[17] FUSARO M, CREPALDI G, MAGGI S, et al. Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: An important but poorly studied relationship [J]. Journal of Endocrinological Investigation, 2011, 34(3): 317-323.
[18] 王烨明. 抗高血压药与骨质疏松症[J].中国骨质疏松杂志,2016,22(9):1184-1187.
[19] SPRINI D, RINI G B, DI STEFANO L, et al. Correlation between osteoporosis and cardiovascular disease [J]. Clin Cases Miner Bone Metab,2014,11(1):117-119.
[20] BOLLAND M J, AVENELL A, BARON J A. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis [J]. BMJ, 2010, 341: 3691.